Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.

Auteurs : Criscitiello C, Azim HA, de Azambuja E, Rubio IT
Jaar : 2014
Journal : Ann Oncol
Volume : 25(4)
Pagina's : 910-1